Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Biotage AB    BIOT   SE0000454746

BIOTAGE AB

(BIOT)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Biotage : Upgraded Flash System Capabilities Improve Purification Performance

share with twitter share with LinkedIn share with facebook
04/07/2015 | 08:39am EDT
Higher default flow rates in Isolera™ flash systems decreases purification times compared to other systems, without sacrificing separation efficiency. This is the conclusion of a new poster recently presented at ACS in Denver.

The default flow rates and linear gradient profiles on flash systems are often suboptimal for maximum purification performance. To ensure the best possible purification results, Biotage has updated its market leading Isolera™ flash purification systems with optimized flow rates. The updated ACI™ (Accelerated Chromatographic Isolation) systems reduce flash purification durations compared to conventional flash systems, saving time and expense.

This poster shows examples of how Isolera ACI systems speed the purification process without compromising product purity.

distributed by
share with twitter share with LinkedIn share with facebook
All news about BIOTAGE AB
07/17BIOTAGE AB : (publ) Interim report January - June 2020
AQ
06/04BIOTAGE : Resolutions at the Annual General Meeting in Biotage AB on June 4, 202..
AQ
04/30BIOTAGE : Chairman of the Board has sold part of his shares in Biotage - remains..
AQ
04/28BIOTAGE AB : (publ) Interim report January - March 2020
AQ
04/28BIOTAGE AB : (publ) publishes its 2019 Annual Report and Corporate Governance Re..
AQ
04/17BIOTAGE : Board withdraw the dividend proposal
AQ
03/27BIOTAGE : Update on Biotage's COVID-19 Response Plan
PU
03/26BIOTAGE : postpones the AGM until June 4, 2020
AQ
03/23GENOVIS PUBL : Nomination Committee proposes Torben Jørgensen for new chairman o..
AQ
03/17BIOTAGE AB : (publ) appoints new CFO
AQ
More news
Financials
Sales 2020 1 059 M 122 M 122 M
Net income 2020 141 M 16,3 M 16,3 M
Net cash 2020 219 M 25,3 M 25,3 M
P/E ratio 2020 77,0x
Yield 2020 1,08%
Capitalization 10 843 M 1 249 M 1 250 M
EV / Sales 2020 10,0x
EV / Sales 2021 8,26x
Nbr of Employees 467
Free-Float 95,9%
Chart BIOTAGE AB
Duration : Period :
Biotage AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOTAGE AB
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 159,00 SEK
Last Close Price 166,30 SEK
Spread / Highest target -4,39%
Spread / Average Target -4,39%
Spread / Lowest Target -4,39%
EPS Revisions
Managers
NameTitle
Tomas Blomquist President & Chief Executive Officer
Torben Vedel Stahl Jörgensen Chairman
Anders Wikström Vice President-Operations
Annette Colin Lövgren Chief Financial Officer
Steve Jordan Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
BIOTAGE AB34.11%1 249
SARTORIUS AG54.29%24 725
CELLAVISION AB (PUBL)-5.54%829
VAREX IMAGING CORPORATION-46.33%623
CO-DIAGNOSTICS, INC.2,086.10%538
ALPHATEC HOLDINGS, INC.-17.41%379